Image 1
Chemical structure of disopyramide phosphate, showing molecular components and phosphate group as part of the active ingredient representation.*
Disopyramide Phosphate Capsule
Product Images NDC 0093-3127
3 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Disopyramide Phosphate (NDC 0093-3127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Disopyramide Phosphate Capsules, USP 100 mg, oral dosage form, shown on a prescription drug label. The label indicates a package of 100 capsules, manufactured by Teva Pharmaceuticals USA, Inc. The label includes storage conditions, dosage instructions, and an NDC number 0093-3127-01.*
Image 3
Label for Disopyramide Phosphate Capsules, USP 150 mg, an oral prescription drug by Teva Pharmaceuticals USA, Inc. The label indicates the package contains 100 capsules. It includes storage instructions, a barcode, NDC number 0093-3129-01, and trademarked logo of Teva in green. Serialization coding area is also visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
